Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › thalidomide

thalidomide

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of thalidomide

47 trials tracked of thalidomide: 12 in phase 3 or 4 and 5 with published results. The most-cited published study has 277 citations.

47Trials tracked
12Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 1 Phase 3 11 Phase 2 34 Other / NA 1
  1. Phase 3 Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Completed · 277 cited
  2. Phase 3 Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide Completed · 204 cited
  3. Phase 3 Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma Completed · 144 cited
  4. Phase 3 Velcade (Bortezomib) Consolidation After Transplant Completed · 17 cited
  5. Phase 4 Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases Completed · 14 cited
  6. Phase 3 Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Completed
Show 41 more trials
  1. Phase 3 Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone Completed
  2. Phase 3 DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation Completed
  3. Phase 3 Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer Completed
  4. Phase 3 UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy Completed
  5. Phase 3 Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma Completed
  6. Phase 3 A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma Completed
  7. Phase 2 Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma Completed
  8. Phase 2 Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma Completed
  9. Phase 2 A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life Completed
  10. Phase 2 Optimising Renal Outcome in Myeloma Renal Failure Completed
  11. Phase 2 S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Completed
  12. Phase 2 A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis Completed
  13. Phase 2 Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Completed
  14. Phase 2 S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma Completed
  15. Phase 2 R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma Completed
  16. Phase 2 Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma Completed
  17. Phase 2 GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer Completed
  18. Phase 2 Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas Completed
  19. Phase 2 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Completed
  20. Phase 2 Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma Completed
  21. Phase 2 Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165 Completed
  22. Phase 2 Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer Completed
  23. Phase 2 Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma Completed
  24. Phase 2 Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma Completed
  25. Phase 2 Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia Completed
  26. Phase 2 Bortezomib, Doxorubicin Hydrochloride Liposome, and Dexamethasone Followed by Thalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Multiple Myeloma Completed
  27. Phase 2 Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma Completed
  28. Phase 2 Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) Completed
  29. Phase 2 Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas Completed
  30. Phase 2 The Effects of Thalidomide on Symptom Clusters Completed
  31. Phase 2 UARK 2003-33, Total Therapy III Completed
  32. Phase 2 Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma Completed
  33. Phase 2 Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia Completed
  34. Phase 2 Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma Completed
  35. Phase 2 Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer Completed
  36. Phase 2 Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Completed
  37. Phase 2 Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation Completed
  38. Phase 2 Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer Completed
  39. Phase 2 Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide Completed
  40. Phase 2 Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL Completed
  41. N/A Effects of Exercise in Combination With Epoetin Alfa Completed

Showing the 47 most-cited and recently-updated of 47 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oral tofacitinib monotherapy with fire needling induced marked regression of cutaneous Rosai-Dorfman disease lesions in a single patient
Neurology Sys. Review
Oral tofacitinib monotherapy with fire needling induced marked regression of cutaneous Rosai-Dorfman disease lesions in a single patient A pill and a heated needle tamed a stubborn face disease
This case report and literature review describes a 55-year-old female with refractory cutaneous Rosai-Dorfman disease who failed prior thera…
A woman whose face was covered in stubborn red nodules finally saw improvement when doctors tried a surprising combination that crossed medi…
Frontiers Apr 13, 2026
Early daratumumab or immunomodulatory agents in high-risk smoldering multiple myeloma show uncertain benefits versus observation
Allergy & Immunology Sys. Review
Early daratumumab or immunomodulatory agents in high-risk smoldering multiple myeloma show uncertain benefits versus observation Early Drug May Delay Multiple Myeloma
This systematic review evaluated early intervention with monoclonal antibodies, immunomodulatory agents, or alkylating agents versus observa…
Imagine waking up with a headache. You take a pill, and the pain goes away.
Cochrane Apr 10, 2026